Patorno, E., Gopalakrishnan, C., Brodovicz, K., Meyers, A., Bartels, D., Liu, J., . . . Schneeweiss, S. (2019). Cardiovascular safety of linagliptin compared to other oral glucose lowering agents in patients with type 2 diabetes: A sequential monitoring program in routine care. Diabetes Obes Metab.

Patorno, E., C. Gopalakrishnan, KG Brodovicz, A. Meyers, DB Bartels, J. Liu, M. Kulldorff, und S. Schneeweiss. "Cardiovascular Safety of Linagliptin Compared to Other Oral Glucose Lowering Agents in Patients With Type 2 Diabetes: A Sequential Monitoring Program in Routine Care." Diabetes Obes Metab 2019.

Patorno, E., et al. "Cardiovascular Safety of Linagliptin Compared to Other Oral Glucose Lowering Agents in Patients With Type 2 Diabetes: A Sequential Monitoring Program in Routine Care." Diabetes Obes Metab 2019.